REQUEST A DEMO
Total
USD $0.00
Search more companies

Phaarmasia Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Phaarmasia Ltd. Profile Updated: November 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Phaarmasia Ltd. manufactures and sells pharmaceutical products and bulk drugs primarily in India. The company offers formulations, cosmetics and oral contraceptive pills. Phaarmasia is listed in Bombay Stock Exchange. The company was founded in 1981 and ...

Legal Address
16, Phase III,, IDA, Jeedimetla,
Hyderabad; Telangana; Postal Code: 500055

Contact Details: Purchase the Phaarmasia Ltd. report to view the information.

Website: http://www.phaarmasia.com

Basic Information
Total Employees:
Purchase the Phaarmasia Ltd. report to view the information.
Outstanding Shares:
Purchase the Phaarmasia Ltd. report to view the information.
Registered Capital:
Purchase the Phaarmasia Ltd. report to view the information.
Financial Auditors:
Purchase the Phaarmasia Ltd. report to view the information.
Incorporation Date:
1981
Key Executives
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Non Executive Director
Purchase this report to view the information.
Non Executive Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
73.51%
Purchase this report to view the information.
26.18%
Purchase this report to view the information.
0.25%
Purchase this report to view the information.
0.06%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Phaarmasia Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
11.29%
Total operating revenue
11.49%
Operating profit (EBIT)
61.55%
EBITDA
81.55%
Net Profit (Loss) for the Period
58.85%
Total assets
10.64%
Total equity
-4.73%
Operating Profit Margin (ROS)
3.31%
Net Profit Margin
2.89%
Return on Equity (ROE)
6.62%
Debt to Equity Ratio
0.68%
Quick Ratio
-0.05%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?